Click for best price
Approved COVID19 Vaccines Market Size, Share 2022
This report contains market size and forecasts of Approved COVID-19 Vaccines in global, including the following market information:
Global Approved COVID-19 Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Approved COVID-19 Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Approved COVID-19 Vaccines companies in 2021 (%)
The global Approved COVID-19 Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Component Viral Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Approved COVID-19 Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Approved COVID-19 Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Type, 2021 (%)
Component Viral Vaccines
Whole Virus Vaccines
Global Approved COVID-19 Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Elderly
Global Approved COVID-19 Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Approved COVID-19 Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Approved COVID-19 Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Approved COVID-19 Vaccines revenues share in global market, 2021 (%)
Key companies Approved COVID-19 Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Approved COVID-19 Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson?Johnson
Heat Biologics
Sanofi
| Report Attributes |
Report Details |
| Report Title |
Approved COVID-19 Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Approved COVID-19 Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Approved COVID-19 Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Approved COVID-19 Vaccines Overall Market Size
2.1 Global Approved COVID-19 Vaccines Market Size: 2021 VS 2028
2.2 Global Approved COVID-19 Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Approved COVID-19 Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Approved COVID-19 Vaccines Players in Global Market
3.2 Top Global Approved COVID-19 Vaccines Companies Ranked by Revenue
3.3 Global Approved COVID-19 Vaccines Revenue by Companies
3.4 Global Approved COVID-19 Vaccines Sales by Companies
3.5 Global Approved COVID-19 Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Approved COVID-19 Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Approved COVID-19 Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Approved COVID-19 Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Approved COVID-19 Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Approved COVID-19 Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Approved COVID-19 Vaccines Market Size Markets, 2021 & 2028
4.1.2 Component Viral Vaccines
4.1.3 Whole Virus Vaccines
4.2 By Type - Global Approved COVID-19 Vaccines Revenue & Forecasts
4.2.1 By Type - Global Approved COVID-19 Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Approved COVID-19 Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Approved COVID-19 Vaccines Sales & Forecasts
4.3.1 By Type - Global Approved COVID-19 Vaccines Sales, 2017-2022
4.3.2 By Type - Global Approved COVID-19 Vaccines Sales, 2023-2028
4.3.3 By Type - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Approved COVID-19 Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Approved COVID-19 Vaccines Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.1.4 Elderly
5.2 By Application - Global Approved COVID-19 Vaccines Revenue & Forecasts
5.2.1 By Application - Global Approved COVID-19 Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Approved COVID-19 Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Approved COVID-19 Vaccines Sales & Forecasts
5.3.1 By Application - Global Approved COVID-19 Vaccines Sales, 2017-2022
5.3.2 By Application - Global Approved COVID-19 Vaccines Sales, 2023-2028
5.3.3 By Application - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Approved COVID-19 Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Approved COVID-19 Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Approved COVID-19 Vaccines Revenue & Forecasts
6.2.1 By Region - Global Approved COVID-19 Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Approved COVID-19 Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Approved COVID-19 Vaccines Sales & Forecasts
6.3.1 By Region - Global Approved COVID-19 Vaccines Sales, 2017-2022
6.3.2 By Region - Global Approved COVID-19 Vaccines Sales, 2023-2028
6.3.3 By Region - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Approved COVID-19 Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Approved COVID-19 Vaccines Sales, 2017-2028
6.4.3 US Approved COVID-19 Vaccines Market Size, 2017-2028
6.4.4 Canada Approved COVID-19 Vaccines Market Size, 2017-2028
6.4.5 Mexico Approved COVID-19 Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Approved COVID-19 Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Approved COVID-19 Vaccines Sales, 2017-2028
6.5.3 Germany Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.4 France Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.5 U.K. Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.6 Italy Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.7 Russia Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Approved COVID-19 Vaccines Market Size, 2017-2028
6.5.9 Benelux Approved COVID-19 Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Approved COVID-19 Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Approved COVID-19 Vaccines Sales, 2017-2028
6.6.3 China Approved COVID-19 Vaccines Market Size, 2017-2028
6.6.4 Japan Approved COVID-19 Vaccines Market Size, 2017-2028
6.6.5 South Korea Approved COVID-19 Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Approved COVID-19 Vaccines Market Size, 2017-2028
6.6.7 India Approved COVID-19 Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Approved COVID-19 Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Approved COVID-19 Vaccines Sales, 2017-2028
6.7.3 Brazil Approved COVID-19 Vaccines Market Size, 2017-2028
6.7.4 Argentina Approved COVID-19 Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, 2017-2028
6.8.3 Turkey Approved COVID-19 Vaccines Market Size, 2017-2028
6.8.4 Israel Approved COVID-19 Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Approved COVID-19 Vaccines Market Size, 2017-2028
6.8.6 UAE Approved COVID-19 Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Moderna
7.1.1 Moderna Corporate Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna Approved COVID-19 Vaccines Major Product Offerings
7.1.4 Moderna Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Moderna Key News
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Corporate Summary
7.2.2 CanSino Biologicals Business Overview
7.2.3 CanSino Biologicals Approved COVID-19 Vaccines Major Product Offerings
7.2.4 CanSino Biologicals Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 CanSino Biologicals Key News
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Corporate Summary
7.3.2 Inovio Pharmaceuticals Business Overview
7.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Major Product Offerings
7.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Inovio Pharmaceuticals Key News
7.4 Shenzhen Geno-Immune Medical Institute
7.4.1 Shenzhen Geno-Immune Medical Institute Corporate Summary
7.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
7.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Major Product Offerings
7.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Shenzhen Geno-Immune Medical Institute Key News
7.5 GlaxoSmithKine
7.5.1 GlaxoSmithKine Corporate Summary
7.5.2 GlaxoSmithKine Business Overview
7.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Major Product Offerings
7.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKine Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Approved COVID-19 Vaccines Major Product Offerings
7.6.4 Pfizer Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Johnson?Johnson
7.7.1 Johnson?Johnson Corporate Summary
7.7.2 Johnson?Johnson Business Overview
7.7.3 Johnson?Johnson Approved COVID-19 Vaccines Major Product Offerings
7.7.4 Johnson?Johnson Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Johnson?Johnson Key News
7.8 Heat Biologics
7.8.1 Heat Biologics Corporate Summary
7.8.2 Heat Biologics Business Overview
7.8.3 Heat Biologics Approved COVID-19 Vaccines Major Product Offerings
7.8.4 Heat Biologics Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Heat Biologics Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Approved COVID-19 Vaccines Major Product Offerings
7.9.4 Sanofi Approved COVID-19 Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Sanofi Key News
8 Global Approved COVID-19 Vaccines Production Capacity, Analysis
8.1 Global Approved COVID-19 Vaccines Production Capacity, 2017-2028
8.2 Approved COVID-19 Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Approved COVID-19 Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Approved COVID-19 Vaccines Supply Chain Analysis
10.1 Approved COVID-19 Vaccines Industry Value Chain
10.2 Approved COVID-19 Vaccines Upstream Market
10.3 Approved COVID-19 Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Approved COVID-19 Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Approved COVID-19 Vaccines in Global Market
Table 2. Top Approved COVID-19 Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Approved COVID-19 Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Approved COVID-19 Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Approved COVID-19 Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Approved COVID-19 Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Approved COVID-19 Vaccines Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Approved COVID-19 Vaccines Product Type
Table 9. List of Global Tier 1 Approved COVID-19 Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Approved COVID-19 Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Approved COVID-19 Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Approved COVID-19 Vaccines Sales (K Units), 2023-2028
Table 16. By Application ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Approved COVID-19 Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Approved COVID-19 Vaccines Sales (K Units), 2023-2028
Table 21. By Region ? Global Approved COVID-19 Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Approved COVID-19 Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Approved COVID-19 Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Approved COVID-19 Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Approved COVID-19 Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Approved COVID-19 Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Approved COVID-19 Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Approved COVID-19 Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Approved COVID-19 Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Approved COVID-19 Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Approved COVID-19 Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Approved COVID-19 Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Approved COVID-19 Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Approved COVID-19 Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales, (K Units), 2023-2028
Table 46. Moderna Corporate Summary
Table 47. Moderna Approved COVID-19 Vaccines Product Offerings
Table 48. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CanSino Biologicals Corporate Summary
Table 50. CanSino Biologicals Approved COVID-19 Vaccines Product Offerings
Table 51. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Inovio Pharmaceuticals Corporate Summary
Table 53. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Offerings
Table 54. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Shenzhen Geno-Immune Medical Institute Corporate Summary
Table 56. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Offerings
Table 57. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GlaxoSmithKine Corporate Summary
Table 59. GlaxoSmithKine Approved COVID-19 Vaccines Product Offerings
Table 60. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Approved COVID-19 Vaccines Product Offerings
Table 63. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Johnson?Johnson Corporate Summary
Table 65. Johnson?Johnson Approved COVID-19 Vaccines Product Offerings
Table 66. Johnson?Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Heat Biologics Corporate Summary
Table 68. Heat Biologics Approved COVID-19 Vaccines Product Offerings
Table 69. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sanofi Corporate Summary
Table 71. Sanofi Approved COVID-19 Vaccines Product Offerings
Table 72. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Approved COVID-19 Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 74. Global Approved COVID-19 Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Approved COVID-19 Vaccines Production by Region, 2017-2022 (K Units)
Table 76. Global Approved COVID-19 Vaccines Production by Region, 2023-2028 (K Units)
Table 77. Approved COVID-19 Vaccines Market Opportunities & Trends in Global Market
Table 78. Approved COVID-19 Vaccines Market Drivers in Global Market
Table 79. Approved COVID-19 Vaccines Market Restraints in Global Market
Table 80. Approved COVID-19 Vaccines Raw Materials
Table 81. Approved COVID-19 Vaccines Raw Materials Suppliers in Global Market
Table 82. Typical Approved COVID-19 Vaccines Downstream
Table 83. Approved COVID-19 Vaccines Downstream Clients in Global Market
Table 84. Approved COVID-19 Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Approved COVID-19 Vaccines Segment by Type
Figure 2. Approved COVID-19 Vaccines Segment by Application
Figure 3. Global Approved COVID-19 Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Approved COVID-19 Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Approved COVID-19 Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Approved COVID-19 Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Approved COVID-19 Vaccines Revenue in 2021
Figure 9. By Type - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Approved COVID-19 Vaccines Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Approved COVID-19 Vaccines Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 19. US Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 33. China Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Approved COVID-19 Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Approved COVID-19 Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Approved COVID-19 Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Approved COVID-19 Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Approved COVID-19 Vaccines by Region, 2021 VS 2028
Figure 50. Approved COVID-19 Vaccines Industry Value Chain
Figure 51. Marketing Channels
